China Pharma Holdings (CPHI)

$1.60 -0.04 (-2.44%)
Market Cap 5.35M
Revenue (ttm) 4.53M
Net Income (ttm) -4.74M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -104.64%
Debt to Equity Ratio 0.33
Volume 723,600
Avg Vol 109,610
Day's Range N/A - N/A
Shares Out 3.26M
Stochastic %K 22%
Beta 0.87
Analysts Strong Buy
Price Target $4.50

Company Profile

China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylg...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 86 89 8668 11730
Fax: 86 89 8668 19024
Address:
No. 17, Jinpan Road, Second Floor, Haikou, China
Rampart1
Rampart1 Aug. 4 at 9:16 PM
$CPHI hella shakeout. Wow.
0 · Reply
I_Need_A_Winner
I_Need_A_Winner Aug. 4 at 8:02 PM
$CPHI i am not 100%confident the float is as low as we think it is. hope im wrong. but being a china stock, have to remain skeptical.
0 · Reply
Rampart1
Rampart1 Aug. 4 at 7:00 PM
$CPHI its def shakeout. low floats it can happen easily.
0 · Reply
Haneos
Haneos Aug. 4 at 6:55 PM
$CPHI 😎🛫
0 · Reply
Company97
Company97 Aug. 4 at 6:38 PM
$CPHI This stock is done😬
0 · Reply
Ronin232
Ronin232 Aug. 4 at 6:08 PM
$CPHI I’m sure if you buy now it will swing back to $1.80 🤷‍♂️
0 · Reply
Stockamateur
Stockamateur Aug. 4 at 5:41 PM
$CPHI wth is happening?
0 · Reply
Rampart1
Rampart1 Aug. 4 at 4:40 PM
$CPHI on SSR now. clearly being walked down. hmm
0 · Reply
onestudy
onestudy Aug. 4 at 4:15 PM
$CPHI CPHI Wins NEW Government Contract for Stroke Drug! Usually, these government contracts are updated on Chinese official pages after about 2 weeks, and it was just updated that CPHI has won a Chinese government contract for its Ozagrel Sodium, a stroke treatment drug, on July 25, 2025. I’ll attach the original Chinese-language screenshot showing the details of the CPHI contract for double checking. For midday trading today, $VERB is trending at #3 after announcing a private placement deal to establish a Toncoin treasury strategy, and it's currently up more than 80%. $COMM is surging over 70% as the community talks about a potential special dividend following a large cash deal. In the #3 spot, $QNTM is up 10% amid a lawsuit alleging market manipulation and seeking damages. Lastly, $JOBY is soaring more than 20% on the news of acquiring Blade Air Mobility. Let’s all make some money today!!
1 · Reply
onestudy
onestudy Aug. 4 at 2:50 PM
$CPHI I think new buyers and anyone who added today should drop a Hello comment. I’ll go first. Hello! Let’s see some green today! 💪🚀
0 · Reply
Latest News on CPHI
China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split

Apr 4, 2025, 4:05 PM EDT - 4 months ago

China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split

China Pharma Holdings, Inc. Completes Full Redemptions Under Convertible Note Agreement with Streeterville

Dec 18, 2024, 8:30 AM EST - 8 months ago

China Pharma Holdings, Inc. Completes Full Redemptions Under Convertible Note Agreement with Streeterville

China Pharma Announces the Entry of "At-The-Market" Equity Offering

Dec 13, 2024, 8:00 AM EST - 8 months ago

China Pharma Announces the Entry of "At-The-Market" Equity Offering

China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025

Aug 19, 2024, 8:00 AM EDT - 1 year ago

China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025

China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split

Feb 23, 2024, 4:05 PM EST - 1 year ago

China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split

China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device

Nov 29, 2023, 8:00 AM EST - 1 year ago

China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device

China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic Drugs

Aug 9, 2023, 8:30 AM EDT - 2 years ago

China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic Drugs

China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective Mask

Dec 28, 2022, 8:00 AM EST - 2 years ago

China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective Mask

China Pharma Holdings, Inc. Announced that several products are included in the Catalogue of Medicines for People Infected with COVID-19

Dec 15, 2022, 8:00 AM EST - 2 years ago

China Pharma Holdings, Inc. Announced that several products are included in the Catalogue of Medicines for People Infected with COVID-19

China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device Project

Dec 5, 2022, 8:00 AM EST - 2 years ago

China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device Project

China Pharma Announces Receipt of Noncompliance Notice from NYSE American

Dec 2, 2022, 4:10 PM EST - 2 years ago

China Pharma Announces Receipt of Noncompliance Notice from NYSE American

China Pharma Announces Receipt of Notification of NYSE American Listing Deficiency

Oct 1, 2022, 10:05 PM EDT - 3 years ago

China Pharma Announces Receipt of Notification of NYSE American Listing Deficiency

China Pharma Announced the Submission of a Plan of Compliance to NYSE American

Jul 18, 2022, 8:00 AM EDT - 3 years ago

China Pharma Announced the Submission of a Plan of Compliance to NYSE American

China Pharma Holdings, Inc. Reports Fiscal Year 2021 Financial Results

Mar 31, 2022, 8:00 AM EDT - 3 years ago

China Pharma Holdings, Inc. Reports Fiscal Year 2021 Financial Results

China Pharma Holdings, Inc. Reports Third Quarter 2021 Financial Results

Nov 12, 2021, 4:30 PM EST - 4 years ago

China Pharma Holdings, Inc. Reports Third Quarter 2021 Financial Results

China Pharma Holdings, Inc. Reports Second Quarter 2021 Financial Results

Aug 13, 2021, 4:30 PM EDT - 4 years ago

China Pharma Holdings, Inc. Reports Second Quarter 2021 Financial Results

China Pharma's Candesartan Hypertension Product Passes Bioequivalence Tests and the Company Plans to Apply for NMPA Approval

Aug 5, 2021, 9:00 AM EDT - 4 years ago

China Pharma's Candesartan Hypertension Product Passes Bioequivalence Tests and the Company Plans to Apply for NMPA Approval

China Pharma to Launch Highly Purified NMN+PQQ Product

Jun 9, 2021, 8:00 AM EDT - 4 years ago

China Pharma to Launch Highly Purified NMN+PQQ Product

China Pharma Holdings, Inc. Reports 33% YoY Increase in First Quarter 2021 Revenue

May 14, 2021, 4:30 PM EDT - 4 years ago

China Pharma Holdings, Inc. Reports 33% YoY Increase in First Quarter 2021 Revenue

China Pharma Expects Considerable Increase in Growth Opportunities Related to Hainan Free Trade Port

Apr 19, 2021, 8:30 AM EDT - 4 years ago

China Pharma Expects Considerable Increase in Growth Opportunities Related to Hainan Free Trade Port

China Pharma Holdings, Inc. Reports Fiscal Year 2020 Financial Results

Mar 26, 2021, 5:00 PM EDT - 4 years ago

China Pharma Holdings, Inc. Reports Fiscal Year 2020 Financial Results

China Pharma Holdings Inc. (CPHI) CEO Zhilin Li on Q4 2019 Results - Earnings Call Transcript

Mar 31, 2020, 9:36 AM EDT - 5 years ago

China Pharma Holdings Inc. (CPHI) CEO Zhilin Li on Q4 2019 Results - Earnings Call Transcript

China Pharma's (CPHI) CEO Zhilin Li on Q2 2019 Results - Earnings Call Transcript

Aug 15, 2019, 1:13 PM EDT - 6 years ago

China Pharma's (CPHI) CEO Zhilin Li on Q2 2019 Results - Earnings Call Transcript

China Pharma Holdings, Inc. (CPHI) CEO Zhilin Li on Q1 2019 Results - Earnings Call Transcript

May 15, 2019, 10:31 AM EDT - 6 years ago

China Pharma Holdings, Inc. (CPHI) CEO Zhilin Li on Q1 2019 Results - Earnings Call Transcript

China Pharma Holdings, Inc. (CPHI) CEO Zhilin Li on Q4 2018 Results - Earnings Call Transcript

Mar 29, 2019, 1:16 PM EDT - 6 years ago

China Pharma Holdings, Inc. (CPHI) CEO Zhilin Li on Q4 2018 Results - Earnings Call Transcript

Rampart1
Rampart1 Aug. 4 at 9:16 PM
$CPHI hella shakeout. Wow.
0 · Reply
I_Need_A_Winner
I_Need_A_Winner Aug. 4 at 8:02 PM
$CPHI i am not 100%confident the float is as low as we think it is. hope im wrong. but being a china stock, have to remain skeptical.
0 · Reply
Rampart1
Rampart1 Aug. 4 at 7:00 PM
$CPHI its def shakeout. low floats it can happen easily.
0 · Reply
Haneos
Haneos Aug. 4 at 6:55 PM
$CPHI 😎🛫
0 · Reply
Company97
Company97 Aug. 4 at 6:38 PM
$CPHI This stock is done😬
0 · Reply
Ronin232
Ronin232 Aug. 4 at 6:08 PM
$CPHI I’m sure if you buy now it will swing back to $1.80 🤷‍♂️
0 · Reply
Stockamateur
Stockamateur Aug. 4 at 5:41 PM
$CPHI wth is happening?
0 · Reply
Rampart1
Rampart1 Aug. 4 at 4:40 PM
$CPHI on SSR now. clearly being walked down. hmm
0 · Reply
onestudy
onestudy Aug. 4 at 4:15 PM
$CPHI CPHI Wins NEW Government Contract for Stroke Drug! Usually, these government contracts are updated on Chinese official pages after about 2 weeks, and it was just updated that CPHI has won a Chinese government contract for its Ozagrel Sodium, a stroke treatment drug, on July 25, 2025. I’ll attach the original Chinese-language screenshot showing the details of the CPHI contract for double checking. For midday trading today, $VERB is trending at #3 after announcing a private placement deal to establish a Toncoin treasury strategy, and it's currently up more than 80%. $COMM is surging over 70% as the community talks about a potential special dividend following a large cash deal. In the #3 spot, $QNTM is up 10% amid a lawsuit alleging market manipulation and seeking damages. Lastly, $JOBY is soaring more than 20% on the news of acquiring Blade Air Mobility. Let’s all make some money today!!
1 · Reply
onestudy
onestudy Aug. 4 at 2:50 PM
$CPHI I think new buyers and anyone who added today should drop a Hello comment. I’ll go first. Hello! Let’s see some green today! 💪🚀
0 · Reply
ECST
ECST Aug. 4 at 2:31 PM
$CPHI got my limit buy order in, let’s see if it hits before we lift off! 🚀
0 · Reply
Rampart1
Rampart1 Aug. 4 at 2:28 PM
$CPHI shorts rooting out the weak hands and negative people.
0 · Reply
onestudy
onestudy Aug. 4 at 2:17 PM
$CPHI FACT: CPHI applied for a new drug on June 18, 2025, and we’re about to be notified of the next step in the inspection process by the NMPA, which is required to notify the applicant within 40 days.
0 · Reply
onestudy
onestudy Aug. 4 at 2:15 PM
$CPHI CPHI will squeeze up 🚀🚀
0 · Reply
Ronin232
Ronin232 Aug. 4 at 2:03 PM
$CPHI sheeeeeeeeeesh isn’t this swell
0 · Reply
onestudy
onestudy Aug. 4 at 2:01 PM
$CPHI Someone’s working hard to grab your shares cheap. Stop-loss triggered again but I’m not scared. Facts will prevail. Let’s go! 💪💪
0 · Reply
onestudy
onestudy Aug. 4 at 1:59 PM
$CPHI Setting up for a squeeze
0 · Reply
Rampart1
Rampart1 Aug. 4 at 1:55 PM
$CPHI something big is coming. 😲
0 · Reply
Company97
Company97 Aug. 3 at 3:36 PM
$CPHI Strange stock, I believe that stock is going to go down.
1 · Reply
Elaine_Shrimp
Elaine_Shrimp Aug. 1 at 8:31 PM
$CPHI paytience
1 · Reply
onestudy
onestudy Aug. 1 at 7:48 PM
$CPHI Only 1.2M float, 64% insider ownership. When the Zero Tariff news for $CPHI hits the market, this stock will explode with multi-day runs.🚀💥💪
0 · Reply
onestudy
onestudy Aug. 1 at 7:13 PM
$CPHI There’s still tension in U.S.–China trade talks, but the Hainan Free Trade Port policy has already implemented a "Zero Tariff" policy for drugs and medical devices. 💡 Remember: $CPHI (China Pharma Holdings) is the only Hainan-based pharmaceutical company listed on a U.S. exchange — headquartered in Haikou, Hainan. Also, big pharma names are already present in the region: $MRK has a subsidiary located in Chengmai County, Hainan, and $NVS operates within the Bo’ao Lecheng International Medical Tourism Pilot Zone, also in Hainan. CPHI hasn’t really released any operational PR for almost a year — aside from the reverse split news in April. Honestly, it feels like there might be some kind of "deal talk" happening behind the scenes during this quiet period. I know it’s a big speculation to bring up, but those of you who’ve followed my DD on this company know I’ve been digging deep for a long time. Personally, I really believe there’s something going on — if you don’t mind me saying.
0 · Reply